Viral Vector Production Market to grow with a CAGR of 15.45% through 2030
Rising
Prevalence of Genetic Disorders is the major drivers for the Global Viral
Vector Production Market growth in the forecast period, 2026-2030.
According
to TechSci Research report, “Viral Vector Production
Market - Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, Global Viral Vector Production Market stood at
USD 6.71 billion in 2024 and is anticipated to project robust growth in the
forecast period with a CAGR of 15.45% through 2030. The Global Viral
Vector Production Market is anticipated to register a high CAGR during the
forecast period. This can be ascribed to collaborations and partnerships among
leading companies with a diverse approach to merge the expertise of individual
companies and to strengthen their position in the market.
The rising prevalence of genetic disorders is significantly
driving the demand for viral vector production globally. Genetic conditions
like cystic fibrosis, hemophilia, and muscular dystrophy often lack curative
treatments, prompting a surge in gene therapy research. Viral vectors serve as
the backbone of these therapies by delivering corrected genes to affected
cells, positioning them as essential tools in modern medical interventions.
As awareness and diagnosis of genetic disorders improve, the
need for advanced, targeted therapies continues to grow. Viral vectors offer a
promising avenue due to their ability to efficiently and specifically deliver
therapeutic genes. This has fueled investments in vector development, pushing
biopharmaceutical companies and research institutions to expand production
capacity to meet the growing clinical demand.
Furthermore, the rise in newborn screening programs and
genetic testing has led to early detection of many inherited conditions. This
proactive healthcare approach increases the urgency for effective treatments,
boosting the adoption of viral vector-based solutions. As a result, the viral
vector production market is witnessing sustained momentum, driven by the need
to support a growing pipeline of gene therapy candidates.
Browse over
XX market data Figures and spread through XX Pages and an in-depth TOC
on " Global Viral Vector Production Market”
The
Global Viral Vector Production Market segmentation is based on Vector Type,
Workflow, Application, End User, By Company, and Region.
Based on vector
type, Adeno-Associated Virus (AAV) vectors are growing swiftly in
the viral vector production market due to their favorable safety and efficacy
profile. AAV vectors are non-pathogenic, exhibit low immunogenicity, and offer
long-term gene expression, making them ideal for gene therapy applications.
Their ability to target both dividing and non-dividing cells enhances their
therapeutic potential across a wide range of genetic disorders, including
neurological and ocular diseases. Additionally, advancements in AAV engineering
have improved tissue specificity and transduction efficiency. With several
AAV-based therapies receiving regulatory approvals and many more in the
pipeline, the demand for AAV vectors continues to accelerate globally.
Based on region, Asia-Pacific is growing exponentially
in the viral vector production market due to increasing investments in
biotechnology, expanding gene therapy research, and supportive government
initiatives. Countries like China, Japan, South Korea, and India are rapidly
building biomanufacturing infrastructure and fostering innovation in cell and
gene therapies. Additionally, rising awareness, improved healthcare access, and
growing patient populations with genetic disorders are accelerating demand. Regional
collaborations between academic institutions and biotech firms are further
boosting clinical trial activity and production capacity. As regulatory
frameworks mature and local capabilities strengthen, Asia-Pacific is becoming a
key hub for cost-effective and scalable viral vector manufacturing.
Some of
the major companies operating in the United Global Viral Vector Production
Market include:
- Merck kgaa
- FUJIFILM
Diosynth Biotechnologies U.S.A
- Cobra Biologics Ltd.
- Thermofisher Scientific Inc.
- Waisman Biomanufacturing
- Genezen Laboratories
- Advanced
BioScience Laboratories, Inc. (ABL inc.)
- Novasep Holding s.a.s.
- Orgenesis Biotech Israel Ltd
(formerly ATVIO Biotech ltd.)
- Takara Bio Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“Certain
areas, particularly in the Northeast, are projected to exert significant demand
for Viral Vector globally. The growth in the competitive landscape and the
presence of well-established companies in the market, committed to enhance the
overall wellbeing of people each year, are expected to contribute to a
remarkable growth of the Global Viral Vector Production Market in the forecast
period," said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based Global management consulting firm.
"Viral Vector Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vector Type (Adenovirus, AAV, Lentivirus, Retrovirus, others), By Workflow (Upstream Processing, Vector amplification and expansion, Vector recovery/harvesting, Downstream Processing, Purification, Fill finish), By Application (Gene and Cell Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Region and Competition, 2020-2030F", has evaluated the future growth
potential of Global Viral Vector Production Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide innovative market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Viral Vector Production Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
M: +13322586602
Email: [email protected]
Web:
https://www.techsciresearch.com